Watchlist Price Alert

PDS Biotechnology Corpora... (PDSB)

NASDAQ: PDSB · Real-Time Price · USD

1.39

0.06 (4.51%)

At close: May 02, 2025, 3:59 PM

1.39

0.36%

After-hours: May 02, 2025, 04:16 PM EDT

PDS Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	41.69M	56.56M	73.82M	65.24M	28.84M	12.16M	34.65M	88.07M	106.4M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	0.00	0.00	-0.00	-0.00	142.87K	96.06K	90.95K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.36M	2.49M	2.66M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	45.05M	59.06M	76.48M	66.84M	30.34M	14.47M	35.65M	89.05M	107.35M
Property-Plant & Equipment	304.21K	335K	527.53K	357.7K	553.15K	21.05K	426.95K	3.42M	3.42M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	46.8K	51.92K
Total Long-Term Assets	304.21K	335K	527.53K	357.7K	553.15K	21.05K	569.82K	3.57M	3.56M
Total Assets	45.36M	59.39M	77.01M	67.2M	30.89M	14.49M	36.22M	92.62M	110.91M
Account Payables	1.68M	6.98M	1.22M	1.31M	1.42M	1.2M	399.45K	4.37M	3.47M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	25K	6.84K
Short-Term Debt	12.5M	4.17M	n/a	n/a	n/a	n/a	n/a	3.08M	n/a
Other Current Liabilities	2.84M	1.14M	n/a	729.39K	424.6K	498.19K	5.62M	1.91M	1.87M
Total Current Liabilities	17.09M	13.63M	9.82M	3.76M	3.27M	2.79M	6.38M	12.87M	6.68M
Long-Term Debt	9.2M	19.51M	23.02M	n/a	n/a	n/a	30K	17.38M	14.95M
Other Long-Term Liabilities	9.26B	n/a	n/a	n/a	n/a	n/a	291.23K	n/a	n/a
Total Long-Term Liabilities	9.27B	19.63M	23.18M	231.43K	490.35K	n/a	321.23K	17.38M	14.95M
Total Liabilities	26.35M	33.26M	33.01M	3.99M	3.76M	2.79M	6.38M	30.25M	21.64M
Total Debt	21.83M	23.85M	23.47M	490.35K	610.26K	n/a	30K	20.46M	14.95M
Common Stock	12.54K	10.92K	9.96K	9.39K	7.35K	1.74K	10.59K	10.4K	9.76K
Retained Earnings	-182.11B	-144.5M	-101.56M	-60.7M	-43.79M	-28.94M	-192.82M	-151.95M	-101.07M
Comprehensive Income	n/a	n/a	0.00	0.00	0.00	n/a	-451.66K	-305.28K	-122.36K
Shareholders Equity	19B	26.13M	44M	63.21M	27.13M	11.7M	29.84M	62.37M	89.28M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a